Metformin is not bad for most people who take it. It’s one of the most studied medications in the world, with decades of safety data behind it, and it remains the first-line treatment for type 2 diabetes for good reason. The side effects are real but generally mild, the serious risks are extremely rare, and the cardiovascular benefits are significant. That said, it does come with tradeoffs worth understanding.
Digestive Side Effects Are the Main Complaint
The most common problem with metformin is gut discomfort. About 7% of users experience diarrhea, and roughly 5% report abdominal pain. Nausea, bloating, and a metallic taste are also frequent complaints, especially in the first few weeks. These symptoms are annoying but not dangerous, and they tend to fade as your body adjusts.
Starting at a low dose and increasing gradually makes a big difference. The standard approach is to begin at 500 mg once daily and increase by 500 mg each week until reaching the target dose. Taking it with food helps, and the extended-release version causes noticeably fewer stomach problems than the immediate-release tablet. Most people who stick with it through the first month find the side effects settle down.
The B12 Problem Is Real but Manageable
Long-term metformin use can quietly lower your vitamin B12 levels. In the Diabetes Prevention Program, one of the largest and longest studies tracking this issue, about 5% of metformin users had low B12 after five years, rising to roughly 9% after thirteen years. When borderline-low levels were included, about 1 in 5 long-term users were affected.
B12 deficiency matters because it can cause nerve damage, fatigue, memory problems, and anemia. The tricky part is that these symptoms overlap with complications of diabetes itself, so the real cause can be missed. Periodic B12 blood tests (experts have recommended annual screening since the 1970s) catch the problem early, and supplementation reverses it. This isn’t a reason to avoid metformin. It’s a reason to monitor a simple blood level.
Lactic Acidosis: The Risk That Sounds Scarier Than It Is
If you’ve read the metformin warning label, you’ve seen the bold-print warning about lactic acidosis, a dangerous buildup of acid in the blood. This is the side effect people worry about most, and it’s also the rarest. In a study of over 77,000 metformin users, lactic acidosis occurred at a rate of about 10 cases per 100,000 patient-years. None of those cases were fatal, and the vast majority were linked to other serious health problems happening at the same time, like severe infections or dehydration.
The main factor that increases this risk is poor kidney function. Metformin is cleared through the kidneys, so when kidney filtration drops significantly, the drug can accumulate. Current guidelines draw clear lines: metformin should not be used when kidney filtration (measured by eGFR) falls below 30, and it requires careful evaluation and possible dose reduction between 30 and 45. If your kidney function is normal or mildly reduced, this risk is essentially negligible.
Cardiovascular Benefits Are Substantial
This is the other side of the “is it bad for you” question, and it shifts the picture considerably. In the SAVOR-TIMI 53 trial, metformin users had a 25% lower risk of dying from any cause and a 32% lower risk of dying from cardiovascular causes compared to non-users, after adjusting for other differences between the groups. These aren’t small numbers.
Metformin improves how the body handles insulin, reduces blood sugar, and appears to have protective effects on blood vessels that go beyond simple glucose control. For people with type 2 diabetes, where heart disease is the leading cause of death, these benefits are a major part of why metformin has held its position as first-choice therapy for so long.
It Won’t Fix Your Liver (or Help You Lose Much Weight)
Two common expectations about metformin deserve a reality check. First, despite early hopes, metformin does not improve fatty liver disease. Multiple clinical trials in both adults and children found no improvement in liver enzyme levels, liver fat on imaging, or tissue samples under the microscope. Major liver disease guidelines explicitly state that metformin is not recommended as a treatment for fatty liver.
Second, the weight loss is modest. In the Diabetes Prevention Program, metformin users lost an average of about 2 kg (4.4 pounds) over the long term. People who were highly consistent with taking it lost around 3 kg (6.8 pounds). That’s meaningful in a metabolic sense, but if you’re expecting dramatic weight loss from metformin alone, you’ll likely be disappointed. It works better as one piece of a larger strategy.
Medications That Can Cause Problems
Metformin interacts with several common drug categories. Steroids like prednisolone can raise blood sugar and counteract what metformin is doing. Diuretics (water pills), blood pressure medications, and hormonal treatments including birth control pills can all shift blood sugar levels enough to require a dose adjustment. If you’re taking other diabetes medications alongside metformin, the combination increases the risk of blood sugar dropping too low. None of these interactions are dangerous if your prescriber knows what you’re taking, but they do require attention.
What About Anti-Aging Claims?
You may have heard that metformin slows aging. Animal studies and laboratory research suggest it influences cellular processes tied to aging, including inflammation, cell repair, and the accumulation of damaged cells. A completed pilot study (the Metformin in Longevity Study) examined whether metformin could shift gene expression patterns in older adults to look more like those of younger people. Larger trials are underway to test whether metformin actually delays age-related diseases in humans.
The honest answer right now is that we don’t know yet whether metformin extends healthy lifespan in people who don’t have diabetes. The biological signals are interesting, but taking a prescription medication based on preliminary science is a different calculation than taking it for a proven condition. For people with type 2 diabetes, the benefits are well established. For everyone else, the evidence isn’t there yet.